Literature DB >> 19765106

Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite.

Antonio Carlos Victor Canettieri1, Carlos Eduardo Dias Colombo, Chung Man Chin, Horácio Faig-Leite.   

Abstract

Summary An evaluation was made of the local action of alendronate sodium (A), hydroxyapatite (HA) and the association of both substances (A + HA), in different molar concentrations, on the femur bone repair of ovariectomized rats. Ninety-eight animals were divided into seven groups: control (C), starch (S), alendronate 1 mol (A1), alendronate 2 mols (A2), hydroxyapatite 1 mol (HA1), hydroxyapatite 2 mols (HA2) and the association of alendronate + hydroxyapatite (A + HA). Rats weighing about 250 g were ovariectomized and 2.5-mm diameter bone defects were made on the left femur 30 days later. Each experimental group had defects filled with appropriate material, except for group C (control). The animals were killed 7 and 21 days after surgery. Histological, histomorphometric and statistical analyses of bone neoformation in the bone defect site were performed. From the histological standpoint, the major differences occurred after 21 days. All specimens in groups C, S, HA1 and HA2 presented linear closure of the bone defect, and most animals in groups A1, A2 and A + HA showed no bone neoformation in the central area of the defect. No statistically significant difference was found among the experimental groups after 7 days; after 21 days, group HA2 presented the highest amount of neoformed bone. There was no significant difference among groups A1, A2 and A + HA in the two study periods. It was concluded that alendronate, either isolated or in association with hydroxyapatite, had an adverse effect on bone repair in this experimental model. Moreover, the hydroxyapatite used here proved to be biocompatible and osteoconductive, with group HA2 showing the best results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765106      PMCID: PMC2768150          DOI: 10.1111/j.1365-2613.2009.00674.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  22 in total

1.  Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Authors:  M Sato; W Grasser; N Endo; R Akins; H Simmons; D D Thompson; E Golub; G A Rodan
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

2.  Qualitative analysis of peripheral peri-implant bone and influence of alendronate sodium on early bone regeneration.

Authors:  S J Meraw; C M Reeve
Journal:  J Periodontol       Date:  1999-10       Impact factor: 6.993

3.  Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats.

Authors:  I Binderman; M Adut; A Yaffe
Journal:  J Periodontol       Date:  2000-08       Impact factor: 6.993

4.  Histomorphometric analysis of rat alveolar wound healing with hydroxyapatite alone or associated to BMPs.

Authors:  Alexandre C Brandão; Luís Guilherme Brentegani; Arthur B Novaes; Márcio Fernando M Grisi; Sérgio Luís Scombatti de Souza; Mario Taba Júnior; Luiz Antônio Salata
Journal:  Braz Dent J       Date:  2002

5.  Alendronate does not inhibit early bone apposition to hydroxyapatite-coated total joint implants: a preliminary study.

Authors:  Yuichi Mochida; Thomas W Bauer; Toshihiro Akisue; Phillip R Brown
Journal:  J Bone Joint Surg Am       Date:  2002-02       Impact factor: 5.284

6.  Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. a pilot study.

Authors:  Maria Stella Moreira; Emilio Katayama; Antonio Carlos Bombana; Márcia Martins Marques
Journal:  Dent Traumatol       Date:  2005-12       Impact factor: 3.333

7.  Collagen/hydroxylapatite implant for augmenting deficient alveolar ridges: a 24-month clinical and histologic summary.

Authors:  D R Mehlisch
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1989-10

Review 8.  Bone safety of long-term bisphosphonate treatment.

Authors:  Gideon Rodan; Alfred Reszka; Ellis Golub; René Rizzoli
Journal:  Curr Med Res Opin       Date:  2004-08       Impact factor: 2.580

9.  The effect of alendronate on resorption of the alveolar bone following tooth extraction.

Authors:  H Altundal; O Güvener
Journal:  Int J Oral Maxillofac Surg       Date:  2004-04       Impact factor: 2.789

10.  Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.

Authors:  T J Wronski; M Cintrón; L M Dann
Journal:  Calcif Tissue Int       Date:  1988-09       Impact factor: 4.333

View more
  4 in total

1.  Evaluation of the osteogenic effect of low-level laser therapy (808 nm and 660 nm) on bone defects induced in the femurs of female rats submitted to ovariectomy.

Authors:  Rodrigo Ré Poppi; Anísio Lima Da Silva; Renato Silva Nacer; Rodolfo Paula Vieira; Luis Vicente Franco de Oliveira; Newton Santos de Faria Júnior; Paulo de Tarso Camilo Carvalho
Journal:  Lasers Med Sci       Date:  2011-01-19       Impact factor: 3.161

2.  A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects.

Authors:  L Wei; J Ke; I Prasadam; R J Miron; S Lin; Y Xiao; J Chang; C Wu; Y Zhang
Journal:  Osteoporos Int       Date:  2014-05-08       Impact factor: 4.507

3.  Effect of hydroxyapatite bioceramics on the growth of osteoblasts and HIF-α/VEGF signal axis in partial hypoxia environment in vitro.

Authors:  Yanyi Liu; Zekun Gan; Fei Hu
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

4.  Strontium-doped calcium phosphate and hydroxyapatite granules promote different inflammatory and bone remodelling responses in normal and ovariectomised rats.

Authors:  Carina Cardemil; Ibrahim Elgali; Wei Xia; Lena Emanuelsson; Birgitta Norlindh; Omar Omar; Peter Thomsen
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.